摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(2-benzoylhydrazinyl)-4-oxobutanoic acid | 20215-79-6

中文名称
——
中文别名
——
英文名称
4-(2-benzoylhydrazinyl)-4-oxobutanoic acid
英文别名
N-Benzoyl-N'-(3-carboxy-propionyl)-hydrazin;N2-Benzoylbernsteinsaeuremonohydrazid;N'-benzoyl-succinohydrazidic acid;succinic acid mono-(N'-benzoyl-hydrazide);Bernsteinsaeure-mono-(N'-benzoyl-hydrazid);Bernsteinsaeure-mono-benzhydrazid;Monobenzoyl-succinhydrazidsaeure;4-Oxo-4-[2-(phenylcarbonyl)hydrazinyl]butanoic acid
4-(2-benzoylhydrazinyl)-4-oxobutanoic acid化学式
CAS
20215-79-6
化学式
C11H12N2O4
mdl
——
分子量
236.227
InChiKey
BCAYFYHKUBCJIB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.5
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    95.5
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

点击查看最新优质反应信息

文献信息

  • Dual-action inhibitors of HIF prolyl hydroxylases that induce binding of a second iron ion
    作者:Kar Kheng Yeoh、Mun Chiang Chan、Armin Thalhammer、Marina Demetriades、Rasheduzzaman Chowdhury、Ya-Min Tian、Ineke Stolze、Luke A. McNeill、Myung Kyu Lee、Esther C. Y. Woon、Mukram M. Mackeen、Akane Kawamura、Peter J. Ratcliffe、Jasmin Mecinović、Christopher J. Schofield
    DOI:10.1039/c2ob26648b
    日期:——
    Inhibition of the hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD or EGLN enzymes) is of interest for the treatment of anemia and ischemia-related diseases. Most PHD inhibitors work by binding to the single ferrous ion and competing with 2-oxoglutarate (2OG) co-substrate for binding at the PHD active site. Non-specific iron chelators also inhibit the PHDs, both in vitro and in cells. We report the identification of dual action PHD inhibitors, which bind to the active site iron and also induce the binding of a second iron ion at the active site. Following analysis of small-molecule iron complexes and application of non-denaturing protein mass spectrometry to assess PHD2·iron·inhibitor stoichiometry, selected diacylhydrazines were identified as PHD2 inhibitors that induce the binding of a second iron ion. Some compounds were shown to inhibit the HIF hydroxylases in human hepatoma and renal carcinoma cell lines.
    翻译结果: 对缺氧诱导因子(HIF)脯酰羟化酶(PHD或EGLN酶)的抑制在治疗贫血和缺血相关疾病方面备受关注。大多数PHD抑制剂通过结合单个亚离子并与2-氧代戊二酸(2OG)共底物竞争结合PHD活性位点来发挥作用。非特异性螯合剂也能在体外和细胞内抑制PHD。我们报告了双作用PHD抑制剂的鉴定,这些抑制剂不仅与活性位点的结合,还能诱导在活性位点上结合第二个离子。通过对小分子络合物的分析并在非变性蛋白质谱法中评估PHD2··抑制剂的比例后,鉴定出某些二酰基联为诱导第二个离子结合的PHD2抑制剂。有些化合物被证明能抑制人类肝癌和肾癌细胞系中的HIF羟化酶。
  • Cavity-containing supramolecular gels as a crystallization tool for hydrophobic pharmaceuticals
    作者:Lena Kaufmann、Stuart R. Kennedy、Christopher D. Jones、Jonathan W. Steed
    DOI:10.1039/c6cc04037c
    日期:——
    We present two approaches to low-molecular-weight supramolecular gels bearing hydrophobic cavities based on calixarene-containing building blocks. Gels are formed by a calixarene based tetrahydrazide gelator or a co-gel of a...
    我们提出了两种方法,以低分子量超分子凝胶为基础,这些凝胶具有基于含杯芳烃的结构单元的疏腔。凝胶是由基于杯芳烃的四酰胶凝剂或藻土的共凝胶形成的。
  • 1,3,4-Oxadiazoles for Crystal Engineering. Convenient Synthesis and Self-Assembly: Nonchiral Chains versus Chiral Helices
    作者:Oleksii V. Gutov
    DOI:10.1021/cg400649h
    日期:2013.9.4
    A series of new 1,3,4-oxadiazoles containing carboxylic and halogen groups and a double bond have been synthesized in good yields and a multigram scale. This was achieved at room temperature from readily available 1,2-diacylhydrazines using a cheap condensation reagent (the solution of P2O5 in H2SO4). Single-crystal X-ray diffraction analysis has shown that all studied 1,3,4-oxadiazole-containing acids are self-assembled by intermolecular H-bonds into supramolecular zigzag chains or helices, depending on the tecton molecular structure and the type of H-bonding. Factors affecting helix formation have been found, and a Cambridge Structural Database (CSD) survey has been performed to support these findings. Moreover, it has been demonstrated that the tuning of the crystal structure leading to spontaneous symmetry breaking for supramolecular helices based on nonchiral molecules is possible even by as little change in molecular structure as a shift from an isopropyl substituent to a cyclopropyl. Subsequently, the studied 1,3,4-oxadiazole-containing acids and related compounds are found to be easily accessible building blocks for crystal engineering of new chiral materials with tunable supramolecular arrangement.
  • Grekov,A.P.; Skripchenko,V.K., Journal of Organic Chemistry USSR (English Translation), 1968, vol. 4, # 2, p. 236 - 238
    作者:Grekov,A.P.、Skripchenko,V.K.
    DOI:——
    日期:——
  • [EN] NOVEL MDA-9 ANTAGONIST WITH ANTI-METASTATIC POTENTIAL<br/>[FR] NOUVEL ANTAGONISTE DE MDA -9 À POTENTIEL ANTI-MÉTASTATIQUE
    申请人:[en]VIRGINIA COMMONWEALTH UNIVERSITY
    公开号:WO2022216930A1
    公开(公告)日:2022-10-13
    Disclosed herein are, inter cilia, compounds modulating activity and methods of use thereof for treating MDA-9/Syntenin associated conditions or disorders.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫